Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

AstraZeneca PLC ADR (AZN)

NASDAQ
Symbol
Exchange
Currency
AZNNASDAQUSD
AZNlBATS EuropeGBP
AZNsBATS EuropeSEK
AZNCFOTC MarketsUSD
3LAZLondonGBP
AZNLondonGBP
3SAZLondonGBP
AZNNMexicoMXN
AZNNBIVAMXN
AZNStockholmSEK
AZNXetraEUR
AZNTradeGateEUR
AZNFrankfurtEUR
AZNPyFrankfurtEUR
AZNBuenos AiresARS
AZNAViennaEUR
Currency in USD
Disclaimer
68.53
+0.26(+0.39%)
Closed
After Hours
68.51-0.02(-0.03%)

AZN Comments

MOSCOW, June 17 (Reuters) - Moscow is facing a new coronavirus variant that is more aggressive and infectious, and the situation in the city is rapidly deteriorating, Moscow mayor, Sergei Sobyanin said.A new mutation has arrived, a new strain is active. It's more aggressive, it's harder to recover from, it spreads faster. It's much more likely to penetrate a person's immune system," Sobyanin said, according to the RIA news agency.
EU to decide on Astrazeneca's $39 billion Alexion deal by July 5
Once EU approves the deal, AZN will have 5 more profitable drugs to sell worldwide.
AZN vaccines work very well in India and Japan .
AZN Vaccine halted in Italy due to a teenager’s death.
UK study finds AZN vaccines offer 92% protection against hospitalisation from Delta variant
Look at the Gaps, enjoy the speed.
let's go baby, up up & away
all vaccines are effective, experts point out that their efficacy wanes over time, and a booster dose may be needed every year. The company will make profits from Covid-19 vaccines every year.
There is global shortage of coronavirus vaccines, WHO approved AZN vaccine for Emergency Use.
We need to trust scientists, US government and WHO.
Three speculative pumps a while ago. Be careful. This position is short
No one buys from AZ anymore. The vaccines expire. Biden donates because he does not use them. where they will be donated, no one will use them again. AZ is battery operated. 0.001% risk is too high and it is higher. Short.
John Wouters is a liar everywhere, whatever he said is not true.👎
you are the greatest loser of all time a ******who invested in a loser compagny astra loserica
not True politically astra zenica is written down to nill
Covid-19 is still there, vaccinated people are protected, unvaccinated are still in great risk.
AZN is a political stock, no downside risk at this price level and moment.
I got JNJ shot before blood clots side effect cases reported. There's no AZN shot in USA. USA government controls AZN vaccines because Trump administration invested heavily in the company last year.
There's no chance to ban AZN vaccines. USA government will get the investment back for sure. Investors will make profits, shorters will be destroyed
who cares about AZN vaccines, we only care about the stock price. up up & away.
Biden and USA government care AZN vaccines, because trum administration invested heavily in the company for Covid-19 shots last year.
do not take AstraZeneca vaccines. do some research on the blood clots and terrible side effects
Despite blood clots, countries still buy AZN vaccine to end the pandemic of Covid-19. The risk for blood clots is 0.001%.
AZN has invented COVID-19 vaccine, New Tagrisso drug, Anifrolumab showed positive results, acquisition, the company is growing, the stock price to $100 next year.
Biden to donate 60 million doses of AZN COVID-19 vaccine to the world.
Anifrolumab showed benefit across different measures of skin and joint disease activity in patients with systemic lupus erythematosus. Investors will make money, shorters will be destroyed.
New Tagrisso drug and acquisition, AZN is growing, the stock price to $100 next year.
I'm tired of watching this company's tricks and all her pseudo-supporters. This f ..ng sht goes down and there is no going back. Don't miss the fast train down - ray ford and Leo Mu.
I would never use any medicine on Az . No matter how much you advertise , it goes down. No conversion. It kills.
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.